Gregory Grunberg - 09 Feb 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: ETNB
Reported as of: 09 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Feb 2023, 16:34:51 UTC
Prior SEC filing: 18 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Ryan A. Murr, as attorney-in-fact for Gregory Grunberg

Key filing fact

Gregory Grunberg filed Form 4 for 89bio, Inc. (ETNB) on 13 Feb 2023.

Key facts

This page summarizes Gregory Grunberg's Form 4 filing for 89bio, Inc. (ETNB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Feb 2023, 16:34.

Change

Previous filing in this sequence was filed on 18 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ETNB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +27,400
Change %
Price: $0.000000
Shares after: 27,400
Date: 09 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,400
Exercise price: $14.70
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option represents a right to purchase a total of 27,400 shares of the Issuer's Common Stock, which will vest in full on February 9, 2024, subject to the Reporting Person's continued service to the Issuer through such date.